Pharmabiz54m
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers: London, UK Thursday, November 14, 2024, 15:00 Hrs [IST] GSK plc announced t ...
Pharmabiz2h
Researchers uncover new role of mutant proteins in some of the deadliest cancers
Researchers uncover new role of mutant proteins in some of the deadliest cancers: Maryland Thursday, November 14, 2024, 13:00 Hrs [IST] Researchers at the National Institutes of H ...
Pharmabiz4h
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Pharmabiz3h
Islamic Development Bank joins efforts with WHO and development partners to promote health impact investment
As part of its commitment to the global initiative to build stronger primary health care and health systems resilience, the Islamic Development Bank (IsDB) announced an important grant allocation of ...
Pharmabiz2h
MoA working closely with WHO to develop IHP to set global efficacy standards for Ayush products: Ayush secretary
The Union Ministry of Ayush (MoA) is working closely with the World Health Organization (WHO) to develop an International Herbal Pharmacopoeia (IHP) to set global quality and efficacy standards for ...
Pharmabiz7h
UDF proposes need for a centralized drug regulatory cadre, regulatory body in India to bolster patient safety
UDF proposes need for a centralized drug regulatory cadre, regulatory body in India to bolster patient safety: Shardul Nautiyal, Mumbai Thursday, November 14, 2024, 08:00 Hrs [IST ...
Pharmabiz6h
Health Canada approves GSK’s Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anaemia
GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk primary ...
Pharmabiz7h
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues: Our Bureau, New Delhi Thursday, November 14, 2024, 08:00 Hrs [IST] The Drugs Controller General o ...
Pharmabiz7h
PCI to award PMSPPS scholarship to eligible GPAT candidates
Pharma Programme, that the Pradhan Mantri Scholarship for Pharmacy Postgraduate Studies (PMSPPS) will be awarded to eligible ...
Pharmabiz5h
Qiagen collaborates with McGill University to advance microbiome research
Qiagen collaborates with McGill University to advance microbiome research: Montreal, Canada Thursday, November 14, 2024, 10:00 Hrs [IST] Qiagen, a Netherlands-based leading global ...
Pharmabiz7h
Pharmacy college job fairs propel rapport between academia and industry to create capable workforce
Pharmacy college job fairs propel rapport between academia and industry to create capable workforce: Nandita Vijayasimha, Bengaluru Thursday, November 14, 2024, 08:00 Hrs [IST] Ph ...
Pharmabiz20h
US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat adults living with moderate-to-severe Sjögren's disease
Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy designation (BTD) for the treatment of adults living with moderate-to-severe ...